At the recent SEC meeting for endocrinology and metabolism, the expert panel reviewed the proposal along with the ...

The decision comes after evidence suggested these drugs protect the heart and kidneys as well as controlling blood sugar, ...

New draft guidance from the National Institute for Health and Care Excellence suggests the NHS should move away from a ...

A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...

The study tested the effects of balcinrenone/dapagliflozin, a combination drug, in different conditions: fasted, fed, and with the P-gp inhibitor quinidine. The goal was to understand how these ...

The study tested the effects of balcinrenone/dapagliflozin, a drug combination, both in fed and fasted states, and with the addition of quinidine, a P-gp inhibitor. The purpose is to understand how ...

Today’s announcement (August 20) on draft guidelines from the UK’s National Institute for Health and Care Excellence (NICE) ...

HUNDREDS of thousands more Brits could be offered weight loss jabs on the NHS in the biggest shake up of diabetes care in a decade – as the health service prepares to ease rules around ...

The change from the National Institute for Health and Care Excellence will be the most significant for a decade ...

The NHS should move away from a one-size-fits-all approach of starting everyone on the same medication, to more personalised care that aims to prevent complications like heart failure and heart ...